MedPath

A Team Model of Hypertension Care in African Americans

Not Applicable
Completed
Conditions
Hypertension
Interventions
Behavioral: Pharmacy TEAM monitoring and counseling
Registration Number
NCT00205153
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

This Team Education and Adherence Monitoring (TEAM) trial will evaluate the cost-effectiveness of a pharmacy-based intervention in a randomized controlled trial involving 597 treated hypertensive African American patients in five Wisconsin cities. The study involves 28 community pharmacies (14 intervention, 14 control) owned by two pharmacy corporations. Intervention pharmacists and pharmacy technicians implemented a 6-month blood pressure (BP) monitoring program that involved working together as a team with patients and their physicians to achieve improved medication adherence, healthy lifestyles, drug therapy, and hypertension control.

Detailed Description

Researchers screened and enrolled 20-25 subjects in each study pharmacy. Intervention pharmacists and technicians attended a 7-hour TEAM training program on BP monitoring, JNC 7 guidelines, and specially designed tools for assessing and improving medication adherence, lifestyle, patient scheduling and retention, and collaboration with physicians. Intervention teams received specially designed tools, automatic BP monitors, and furniture for setting up and implementing a blood pressure clinic at their pharmacy. Staff from control pharmacies received printed information only and provided "usual care". Outcomes will be determined by blinded data collectors who will re-check patients' BPs and administer follow-up surveys after 6 and 12 months. Researchers also will survey pharmacy staff and review pharmacy records to determine changes in refill adherence and prescribing.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
576
Inclusion Criteria

is African American and 18 years old or older; has active prescription for BP drug; obtains all BP drugs at the study pharmacy; is able to read and fill out short questionnaires; is able to come to pharmacy for 6 monthly pharmacy visits if needed; has screening BP between 140/90 mm Hg and 210/115 mm Hg.

Exclusion Criteria

history of organ transplant or kidney dialysis, symptoms of advanced congestive heart failure, memory impairment that interferes with daily functioning,terminal illness,pregnancy, alcohol or substance abuse problem,physician recommendation of exclusion for other condition that may require special care or limit participation in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TEAM CarePharmacy TEAM monitoring and counselingIntervention pharmacies implement 6-month TEAM program.
Primary Outcome Measures
NameTimeMethod
Proportion of patients achieving hypertension control6 months after enrollment
change in systolic and diastolic blood pressure6 months after enrollment
Secondary Outcome Measures
NameTimeMethod
patient adherence to drug regimen6 months after enrollment
pharmacist adherence to TEAM protocol (intervention fidelity)6 months after enrollment
change in drug prescribing6 months after enrollment
patient-reported barriers to adherence (e.g. bothersome side effects)6 months after enrollment
cost-effectiveness of pharmacy intervention6 months after intervention

Trial Locations

Locations (2)

University of Wisconsin School of Pharmacy

🇺🇸

Madison, Wisconsin, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath